CMV-pp65 CTLs
12-086
Phase 2 mab completed
Quick answer
CMV-pp65 CTLs for Cytomegalovirus is a Phase 2 program (mab) at Atara Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atara Biotherapeutics
- Indication
- Cytomegalovirus
- Phase
- Phase 2
- Modality
- mab
- Status
- completed